Crossmark

Semaglutide targets the Isg15-FUNDC1 axis: suppressing IFN-β overactivation and attenuating blood-brain barrier injury in diabetic intracerebral hemorrhage

Crossref DOI link: https://doi.org/10.1186/s12974-026-03877-1

Published Online: 2026-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Yan

Kuang, Binglin

Chen, Yangwen

Zou, Wei

Zheng, Lei

Zhang, Baiwen

Shang, Tong

Xu, Chengye

Xu, Qian

Li, Hongxue

Hu, Yuxin

Zhao, KangQi

Kuang, Hongyu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No. 82370827)
License Information

Text and Data Mining valid from 2026-05-25

Version of Record valid from 2026-07-21
More Information

Article History

Received: 11 February 2026

Accepted: 13 May 2026

First Online: 25 May 2026

Declarations

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below